Distribution of 5'-nucleotidase in human lymphoid tissues.

N. Lawrence Edwards(University of Michigan), Irving H. Fox(Takeda (United States)), Erwin W. Gelfand(National Jewish Health), Hans‐Michael Dosch(Western University), L. G. Burk
Proceedings of the National Academy of Sciences
July 1, 1979
10.1073/pnas.76.7.3474
Cited by 109

Related Papers

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
The safety of vedolizumab for ulcerative colitis and Crohn's disease
|Gut|2016|810
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694